An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Theressa Henne and Clara Saillant (UNIVIE) The Value of Health Data - Results from the CPDP Moot Court “Honoured judge, We stand in front of your Court today to seek justice and clarity on a matter that is of great concern to our society. My company has...
by Luis Bonmati, Scientific Coordinator of EUCAIM project Presentation of the European Federation for Cancer Images Introducing EUCAIM: A Pan-European Initiative The goal of EUropean Federation for CAncer IMages (EUCAIM) is to build a pan-European digital federated...
Interview with Dr. Kai Vilanova, Director MRI Clínica Girona, Coordinator Radiology, Faculty of Medicine, University of Girona. Director School of MRI-ESMRMB (IDIBGI) How can the results of the ProCAncer-I project help radiologists? What are the problems that...
By Prof Kostas Marias Hellenic Mediterranean University, Head Computational BioΜedicine Lab - FORTH Enabling AI Models Traceability through ProCAncer-I AI Model Passport Artificial intelligence (AI) has brought great economic and social prospects to human society with...
By Ana Castro Verde, Ph.D. student and research technician at Computational Clinical Imaging Group, Champalimaud Foundation Clinical Challenge: Can radical prostatectomy patients help promote a biological validation of radiomics signatures? Prostate cancer patients...
National Cancer Institute is the only specialized oncology institution in Lithuania. The Institute acts as the clinical cancer center, certified and accredited by the Organization of European Cancer Institutes. • In order to achieve our strategic objectives, we...
Established in 2016, Advantis Medical Imaging makes advanced medical imaging more accessible, user-friendly and data-driven by merging it with cloud technology. By providing AI-driven, reliable and automated MRI software solutions, Advantis is on a mission to...
Newsletter #5 Contents
ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...
Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...
The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and ii) include...
ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...